Gulf Pharmaceutical Industries
Last Updated:
- 1.060 AED
- -0.010
- -0.93%
شركة الخليج للصناعات الدوائية
جلفار
Symbol :
JULPHAR
ISIN :
AEG000201018
52-Week Range :
1.040
-
1.630
Turnover Ratio :
0.68
Market :
Abu Dhabi Securities Exchange
Sector :
FTSE ADX Health Care Index
Industry :
Pharmaceuticals and Biotechnology Research & Development
Sub-Industry :
Gulf Pharmaceutical Industries Announcements
Top News
- A 14-August Julphar turns into profitability in H1-25 backed by operations in Egypt
- B 17-November Julphar’s drives portfolio progress in MENA with 14% higher sales in 9M-24
- C 18-August Julphar sees lower net losses in H1-24; revenues up 3%
- D 15-May Julphar turns profitable in Q1-24; accumulated losses announced
- E 17-March Julphar’s 2023 accumulated losses hit 30% of capital; revenues up
- F 13-November Julphar turns to losses in 9M-23; accumulated losses reach 29% of capital
- G 14-August Julphar unveils H1-23 financials; accumulated losses hit AED 295.5m
- H 17-May Julphar shifts to losses in Q1-23; accumulated losses unveiled
- I 09-February Julphar’s CEO resigns; Ziyadeh assumes position
- J 10-November Julphar’s profits to equityholders shrink to AED 10.5m in 9M-22
- K 16-May Julphar turns to profitability in Q1-22
- L 20-March Julphar turns to profitability in 2021
